P. Thompson

OP0114 Beneficial effects of risedronate treatment on bmd and vertebral fracture risk in men on gc therapy

G. Weryha, P. Thompson, RF Laan, 2001 .

A fracture risk profile using single-site bone density assessment and clinical risk factors.

P. Thompson, 2000, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

The Role of Biochemical Tests in the Screening and Monitoring of Osteoporosis

C. Price, P. Thompson, P. Thompson, 1995, Annals of clinical biochemistry.

Identification of an at risk group for osteoporosis using heel ultrasound measurement in primary care

J. Taylor, J. Newth, P. Thompson, 1995 .

Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.

J. McBride, P. Thompson, L. Tee, 2005, Rheumatology.

The annual incidence and seasonal variation of fractures of the distal radius in men and women over 25 years in Dorset, UK.

Paul W Thompson, Julia Taylor, Adrian Dawson, 2004, Injury.

Quantitative Heel Ultrasound in 3180 Women Between 45 and 75 Years of Age: Compliance, Normal Ranges and Relationship to Fracture History

J. Taylor, P. Thompson, A. Fisher, 1998, Osteoporosis International.

Quantitative ultrasound (QUS) of the heel predicts wrist and osteoporosis-related fractures in women age 45-75 years.

P W Thompson, J Taylor, R Oliver, 1998, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Use of clinical risk factors to identify postmenopausal women with vertebral fractures

J. Tobias, E. McCloskey, A. Bhalla, 2006, Osteoporosis International.

Randomized placebo-controlled trial of brisk walking in the prevention of postmenopausal osteoporosis.

S. Ebrahim, S. Ebrahim, P. Thompson, 1997, Age and ageing.

An in-service evaluation of hip protector use in residential homes.

A. Dawson, P. Thompson, Carol Jones, 2005, Age and ageing.